Anemia
News from the FDA/CDC
FDA approves anemia treatment for transfusion-dependent beta thalassemia patients
Luspatercept-aamt (Reblozyl) is approved for adults with beta thalassemia who require regular red blood cell transfusions.
Feature
NIH seeks gene-based cures for HIV, sickle cell disease
The agency is collaborating with the Bill & Melinda Gates Foundation for the $200 million, 4-year project.
Feature
Readmission burden high for those with sickle cell disease
SCD more than doubles the risk of 30-day readmission, compared with non-SCD stays.
Feature
Hypoxia-related discoveries net Nobel Prize
A trio of physician scientists have won the Nobel Prize for their work, which has implications for the treatment of anemia, cancer, and other...
Feature
Ongoing research aims to improve transplant outcomes in sickle cell
Over the past 2 years, the majority of novel transplant techniques have been primarily aimed at improving conditioning regimens and lowering rates...
From the Journals
Can we eradicate malaria by 2050?
A Lancet Commission report details a series of modeled projections that could point the way.
Conference Coverage
Sickle cell unit running 24/7 reduces readmissions, emergency visits
FORT LAUDERDALE, FLA. – An analysis of an around-the-clock sickle cell unit showed significant reductions in per-patient health care utilization...
Conference Coverage
Noninvasive prenatal test may detect sickle cell disease
FORT LAUDERDALE, FLA. – Early data for a noninvasive prenatal test shows it could have the potential to accurately detect sickle cell disease.
Conference Coverage
Crizanlizumab shows posttreatment effect in sickle cell
FORT LAUDERDALE, FLA. – High-dose crizanlizumab may have a beneficial effect on vaso-occlusive events in sickle cell disease patients up to a year...
Conference Coverage
Study: Why urban sickle cell patients quit hydroxyurea
Conference Coverage
Femoral head decompression relieves SCD hip pain
FORT LAUDERDALE, FLA. – Femoral head core decompression with bone marrow aspirate concentrate appears to reduce hip joint pain for sickle cell...